Luxi Chemical: The prices of daily related-party transactions follow the principles of fairness and reasonableness.

Securities Star News: LUXI CHEMICAL (000830) responded to questions of concern from investors on the investor relations platform on April 7.

**Investor: **Hello, Secretary of the Board. In the announcement dated December 22, 2025, the company disclosed a related-party transaction quota as high as 9.37 billion. Given that the controlling shareholder Sinochem Group has strong pricing power on both the procurement and sales sides, how does the company ensure that the profits for the first quarter and the first half are not used as a “savings pool” to be adjusted? Against the backdrop of fluctuations in industry business conditions, will this full-industry-chain internal closed-loop lead the company’s performance to undergo an artificial low-level “run-in” to align with the group-level professional integration milestone, thereby affecting minority shareholders’ assessment of the company’s true value in the secondary market?

**LUXI CHEMICAL Secretary of the Board: **Dear investor, hello. The proposal for the company’s estimated ordinary related-party transactions for fiscal year 2026 has already been approved by the company’s general meeting of shareholders. The prices for ordinary related-party transactions all follow the principles of fair and reasonable pricing. Based on market prices, the transaction parties sign transaction agreements according to the principles of voluntariness, equality, and mutual benefit, and ensure that the prices of the products and services mutually provided do not deviate from prices charged by third parties. There is no situation that harms the company, shareholders, especially the interests of minority shareholders.

The above content has been compiled by Securities Star from publicly available information and generated by an AI algorithm (NetInfo Record No. 310104345710301240019). It does not constitute investment advice.